Is Urethral Catheter Necessary After Ureteroscopy and DJ Stent Placement?
NCT ID: NCT03713411
Last Updated: 2024-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
112 participants
INTERVENTIONAL
2019-04-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ureteral Stenting After Retrograde Intrarenal Surgery for Renal Stones
NCT05738304
Ureteral Stenting After Ureteroscopy for Stone Treatment, A Global Perspective on Indications and Outcomes
NCT03567421
Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis
NCT04594161
Effects of Flexible Ureteroscopy on Renal Blood Flow
NCT03023488
Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy
NCT04649970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
DJ stent placement has the potential side effects such as flank pain and urinary tract infection (UTI) due to retrograde urine flow. As the bladder pressure increases during voiding, urine reflux occurs both beside and through the DJ stent. In order to overcome these problems, stents with antireflux mechanisms are produced, however these new stents comes with higher costs compared to conventional stents.
Foley catheters are the hands and feet of all urologists and insertion of a foley catheter can easily keep the bladder pressures as low as required. The practice of insertion of a foley catheter into the urinary bladder after ureteroscopy for kidney or renal stones and DJ stent placement doesn't have an evidence-based background and it routinely depends on the choice of the surgeon.
The aim of this study is to evaluate whether routine insertion of a bladder catheter following ureteroscopy and DJ stent placement can reduce stent-related problems due to reflux and urinary tract infections.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No-catheter
after semirigid or flexible ureteroscopy + double J stent placement for ureteral or kidney stones, patients in whom a urethral catheter wasn't placed
No interventions assigned to this group
Catheter
urethral catheter placement after semirigid or flexible ureteroscopy + double J stent placement for ureteral or kidney stones
urethral catheter placement
urethral catheter placement to provide low-pressure urinary bladder by providing active drainage of the bladder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
urethral catheter placement
urethral catheter placement to provide low-pressure urinary bladder by providing active drainage of the bladder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with indications for semirigid or flexible ureteroscopy and DJ stent placement for unilateral ureteral and/or kidney stones according to European Association of Urology Urolithiasis Guidelines
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marmara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tarik Emre Sener, MD
Role: PRINCIPAL_INVESTIGATOR
Marmara University Hospital, Department of Urology
Yiloren Tanidir
Role: STUDY_CHAIR
Marmara University Hospital, Department of Urology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marmara University Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MAR.UAD.004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.